TTK Healthcare Ltd
₹908.25
(-0.89%)
Wed, 04 Mar 2026, 05:26 am
Health Technology
Pharmaceuticals: Major
24.5KTTK Healthcare EV/EBITDA Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 28.98 | 20.38 | 4.72 | 9.81 | 21.95 | 21.30 | 19.42 | 22.10 | 32.82 | 44.71 | 31.69 | 32.85 | 81.83 | 39.34 | 37.50 | 15.05 | 28.17 | 2.28 | 33.35 | 20.71 |
| Price to book ratio | 1.59 | 1.38 | 1 | 1.24 | 3.08 | 4.16 | 3.46 | 3.20 | 3.80 | 6.11 | 5.27 | 3.91 | 6.38 | 3.81 | 1.86 | 2.37 | 3.55 | 1.53 | 2.09 | 1.59 |
| Price to sales ratio | 0.31 | 0.29 | 0.29 | 0.35 | 0.79 | 1.01 | 0.86 | 0.82 | 0.98 | 1.50 | 1.40 | 1.17 | 2.57 | 1.53 | 0.72 | 1.47 | 1.96 | 2.01 | 2.78 | 2.11 |
| Price to cash flow ratio | 6.90 | 123.62 | 8.76 | 6.93 | 11.58 | 13.23 | 78.69 | 14.31 | 41.38 | 20.09 | 21.04 | 31.99 | 53.17 | 44.81 | 18.57 | 6.23 | 21.34 | 0 | 42.26 | 29.32 |
| Enterprise value | 569.54M | 489.39M | 209.63M | 421.52M | 1.65B | 2.65B | 2.53B | 2.52B | 3.54B | 6.86B | 6.7B | 5.56B | 13.97B | 8.62B | 3.6B | 4.9B | 9.2B | 6.41B | 12.73B | 8.6B |
| Enterprise value to EBITDA ratio | 8.55 | 7.14 | 3.69 | 3.73 | 10.52 | 12.31 | 10.53 | 12.31 | 18.24 | 23.12 | 18.38 | 14.24 | 32.66 | 16.92 | 12.21 | 24.44 | 40.15 | 19.86 | 32.90 | 23.89 |
| Debt to equity ratio | 0.37 | 0.29 | 0.23 | 0.24 | 0.22 | 0.16 | 0.21 | 0.23 | 0.29 | 0.35 | 0.28 | 0.15 | 0.20 | 0.11 | 0.12 | 0.06 | 0.07 | 0.03 | 0.02 | 0.02 |
| Return on equity % | 0 | 7.10 | 23.14 | 13.19 | 14.40 | 21.02 | 19.16 | 15.28 | 12.08 | 14.35 | 17.81 | 12.76 | 9.47 | 10.06 | 4.92 | 13.53 | 5.93 | 6.96 | 6.43 | 7.90 |
TTK Healthcare Ltd Enterprise Value to EBITDA Ratio
The TTK Healthcare Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate TTK Healthcare Ltd's valuation, profitability, and overall financial performance. Tracking the TTK Healthcare Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
TTK Healthcare Ltd (NSE: TTKHLTCARE, BSE: 507747) is currently trading at ₹908.25, with a market capitalization of ₹12.91B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the TTK Healthcare Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
TTK Healthcare Ltd Enterprise Value to EBITDA Ratio Current Value
The current TTK Healthcare Ltd Enterprise Value to EBITDA Ratio stands at 23.89.
The TTK Healthcare Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
TTK Healthcare Ltd Enterprise Value to EBITDA Ratio Historical Trend
The TTK Healthcare Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 23.89
- 2023: 32.90
- 2022: 19.86
- 2021: 40.15
- 2020: 24.44
The decline in TTK Healthcare Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What TTK Healthcare Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The TTK Healthcare Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of TTK Healthcare Ltd.
TTK Healthcare Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The TTK Healthcare Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking TTK Healthcare Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of TTK Healthcare Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800